Search Results - "Carballido, Estrella"

PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation by Joseph, Richard W, Millis, Sherri Z, Carballido, Estrella M, Bryant, David, Gatalica, Zoran, Reddy, Sandeep, Bryce, Alan H, Vogelzang, Nicholas J, Stanton, Melissa L, Castle, Erik P, Ho, Thai H

“…Monoclonal antibodies that target the programmed death-1 (PD-1)-programmed death ligand-1 (PD-L1) axis have antitumor activity against multiple cancers. The…”
Get more information

Squamous cell carcinoma of the urinary bladder: Systematic review of clinical characteristics and therapeutic approaches by Martin, Jeremy W., Carballido, Estrella M., Ahmed, Ahmed, Farhan, Bilal, Dutta, Rahul, Smith, Cody, Youssef, Ramy F.

Get full text

Adjuvant Chemoradiotherapy in Resected Pancreatic Ductal Adenocarcinoma: Where Does the Benefit Lie? A Nomogram for Risk Stratification and Patient Selection by Naffouje, Samer A., Sabesan, Arvind, Kim, Dae-Won, Carballido, Estrella, Frakes, Jessica, Hodul, Pamela, Denbo, Jason W., Malafa, Mokenge, Fleming, Jason, Hoffe, Sarah

“…Introduction The impact of adjuvant sequential chemoradiotherapy (CRT) on survival in resected pancreatic ductal adenocarcinoma (PDAC) remains unclear and…”
Get full text

UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation by Nelson, Ryan S, Seligson, Nathan D, Bottiglieri, Sal, Carballido, Estrella, Cueto, Alex Del, Imanirad, Iman, Levine, Richard, Parker, Alexander S, Swain, Sandra M, Tillman, Emma M, Hicks, J Kevin

“…Multi-gene assays often include and, in certain instances, may report associated toxicity risks for irinotecan, belinostat, pazopanib, and nilotinib. However,…”
Get full text

Optimal Treatment for Metastatic Bladder Cancer by Carballido, Estrella M., Rosenberg, Jonathan E.

“…Metastatic bladder cancer is a lethal disease. Cisplatin-based chemotherapy, including the combination regimens gemcitabine–cisplatin and…”
Get full text

A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona by Ho, Thai H, Nateras, Rafael Nunez, Yan, Huihuang, Park, Jin G, Jensen, Sally, Borges, Chad, Lee, Jeong Heon, Champion, Mia D, Tibes, Raoul, Bryce, Alan H, Carballido, Estrella M, Todd, Mark A, Joseph, Richard W, Wong, William W, Parker, Alexander S, Stanton, Melissa L, Castle, Erik P

“…To address the need to study frozen clinical specimens using next-generation RNA, DNA, chromatin immunoprecipitation (ChIP) sequencing and protein analyses, we…”
Get full text

Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART) by Bryant, J.M., Palm, Russell F., Liveringhouse, Casey, Boyer, Emanuel, Hodul, Pam, Malafa, Mokenge, Denbo, Jason, Kim, Dae, Carballido, Estrella, Fleming, Jason B., Hoffe, Sarah, Frakes, Jessica

“…Preoperative radiation therapy (RT) for pancreatic adenocarcinoma reduces positive surgical margin rates, and when delivered to an ablative dose range it may…”
Get full text

Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in KRAS Wild-Type Pancreatic Cancer by Fusco, Michael J, Saeed-Vafa, Daryoush, Carballido, Estrella M, Boyle, Theresa A, Malafa, Mokenge, Blue, Kirsten L, Teer, Jamie K, Walko, Christine M, McLeod, Howard L, Hicks, J Kevin, Extermann, Martine, Fleming, Jason B, Knepper, Todd C, Kim, Dae Won

“…It has recently been described that alternative oncogenic drivers may be found in wild-type ( ) pancreatic cancers. This study aimed to determine the incidence…”
Get more information

Racial and ethnic disparities in a state‐wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities by Permuth, Jennifer B., Clark Daly, Ashley, Jeong, Daniel, Choi, Jung W., Cameron, Miles E., Chen, Dung‐Tsa, Teer, Jamie K., Barnett, Tracey E., Li, Jiannong, Powers, Benjamin D., Kumar, Nagalakshmi B., George, Thomas J., Ali, Karla N., Huynh, Tri, Vyas, Shraddha, Gwede, Clement K., Simmons, Vani N., Hodul, Pamela J., Carballido, Estrella M., Judge, Andrew R., Fleming, Jason B., Merchant, Nipun, Trevino, Jose G.

“…Pancreatic cancer (PC) is characterized by racial/ethnic disparities and the debilitating muscle‐wasting condition, cancer cachexia. Florida ranks second in…”
Get full text

Docetaxel Induced Sclerosing Cholangitis by Horsley-Silva, Jennifer L., Dow, Elizabeth N., Menias, Christine O., Smith, Maxwell L., Carballido, Estrella M., Lindor, Keith D., Vargas, Hugo E.

Get full text

The impact of socioeconomic status on survival in stage III colon cancer patients: A retrospective cohort study using the SEER census‐tract dataset by Dhahri, Amina, Kaplan, Jori, Naqvi, Syeda M. H., Brownstein, Naomi C., Ntiri, Shana O., Imanirad, Iman, Felder, Seth I., Dineen, Sean P., Sanchez, Julian, Dessureault, Sophie, Carballido, Estrella, Powers, Benjamin D.

“…Background The impact of socioeconomic status (SES) has been described for screening and accessing treatment for colon cancer. However, little is known about…”
Get full text

Perioperative complications after neoadjuvant chemotherapy and radical cystectomy for bladder cancer by Tyson, 2nd, Mark D, Bryce, Alan H, Ho, Thai H, Carballido, Estrella M, Castle, Erik P

“…Few data on the perioperative outcomes of cystectomy after neoadjuvant chemotherapy (NAC) exist. In this study, we evaluated whether patients who had…”
Get more information

B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature by Trimaldi, Janese, Carballido, Estrella M, Bowers, Jeremy W, Anguiano, Arturo L, Zhang, Zhong J, Shah, Bijal D, Bruno, Salvador, List, Alan F, Moscinski, Lynn C, Grady, Terrence, Agosti, Steven J, Kang, Loveleen, Zhang, Ling

“…Myeloid and lymphoid neoplasms with fibroblastic growth factor receptor-1 (FGFR1) abnormalities originate from mutated pluripotent stem cells and have a…”
Get more information

Efficacy of olaparib therapy in metastatic pancreatic ductal adenocarcinoma (PDAC) with homologous recombination deficiency (HRD) by Tan, Elaine, Hicks, James Kevin, Blue, Kirsten, Kim, Richard D., Carballido, Estrella M., Kim, Dae Won

“…Abstract only e16266 Background: Pancreatic cancer is one of the deadliest malignancies, with a 5 year OS of around 3%. Up to 3% of unselected patients (pts)…”
Get full text

A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer by Kim, Dae Won, Tan, Elaine, Zhou, Jun-Min, Schell, Michael J., Martinez, Maria, Yu, James, Carballido, Estrella, Mehta, Rutika, Strosberg, Jonathan, Imanirad, Iman, Kim, Richard D.

“…Background MMR proficient (pMMR) colorectal cancer (CRC) is usually unresponsive to immunotherapy. Recent data suggest that ibrutinib may enhance the…”
Get full text

Abstract 484: Immune checkpoint inhibitor therapy for metastatic colorectal cancer: Real-world practice patterns and predictors of overall survival by Bari, Shahla, Matejcic, Marco, Kim, Richard, Xie, Hao, Carballido, Estrella, Sahin, Ibrahim, Powers, Benjamin, Felder, Seth, Schmit, Stephanie

“…Abstract There is well-established evidence of a therapeutic role for immune checkpoint inhibitors (ICIs) in mismatch repair deficient (MMR-D) metastatic…”
Get full text

Sipuleucel-T: Prototype for Development of Anti-tumor Vaccines by Carballido, Estrella, Fishman, Mayer

“…Prostate cancer immunotherapy officially debuted with the recent FDA approval of Sipuleucel-T. The novel trend of cancer immunotherapy relies on the…”
Get full text

An intersectional investigation of race and sex on receipt of adjuvant chemotherapy in stage III colon cancer by Dhahri, Amina, Carballido, Estrella M., Felder, Seth, Dineen, Sean Patrick, Powers, Benjamin D

“…Abstract only 86 Background: Race and sex disparities exist for receipt of adjuvant chemotherapy (AC) for stage III colon cancer. However, most studies have…”
Get full text

Investigate the efficacy of immunotherapy for treatment of pancreatic adenocarcinoma (PDAC) with mismatch repair deficiency (dMMR) by Noor, Arish, Aguirre, Luis E., Blue, Kirsten, Avriett, Trenton, Carballido, Estrella M., Kim, Richard D., Kim, Dae Won

“…Abstract only 415 Background: Immune checkpoint inhibitors (ICI) have been approved in solid tumors with dMMR. However, only limited data are available for…”
Get full text

BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal Cancer by Tan, Elaine, Whiting, Junmin, Xie, Hao, Imanirad, Iman, Carballido, Estrella, Felder, Seth, Frakes, Jessica, Mo, Quanxing, Walko, Christine, Permuth, Jennifer B, Sommerer, Katelyn, Kim, Richard, Anaya, Daniel A, Fleming, Jason B, Sahin, Ibrahim Halil

“…Mismatch repair-deficient (MMR-D)/microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) is a unique disease entity with growing interest…”
Get full text